ArticleCells2022

A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models.

Sang-Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.